Muhammad Absar, Tanveer Akhtar, Abid Jameel, Amer Mahmood, Anhar Ullah, Aamer Aleem, Kulsoom Qureshi, Noor Rehman, Zafar Iqbal
The outcome of chronic myeloid leukemia has been greatly improved by the use of Imatinib (IM), a selective BCR/ABL kinase inhibitor
Chronic myeloid leukemia
CML
outcome
risk score
survival